ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000269815.1	Avagacestat	Bladder urothelial carcinoma	0.00776341	Resistant
ENSG00000269815.1	Avagacestat	Head and neck squamous cell carcinoma	0.042818236	Resistant